Home Other Building Blocks 29515-99-9
29515-99-9,MFCD00068726
Catalog No.:AA002YJO

29515-99-9 | 2H-Tetrazole, 5-(methylthio)-

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1g
98%(HPLC)
in stock  
$24.00   $17.00
- +
5g
98%(HPLC)
in stock  
$43.00   $30.00
- +
25g
≥ 99% (HPLC)
in stock  
$85.00   $60.00
- +
100g
≥ 99% (HPLC)
in stock  
$161.00   $113.00
- +
250g
≥ 99% (HPLC)
in stock  
$274.00   $192.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Literature
Technical Information
Catalog Number:
AA002YJO
Chemical Name:
2H-Tetrazole, 5-(methylthio)-
CAS Number:
29515-99-9
Molecular Formula:
C2H4N4S
Molecular Weight:
116.1450
MDL Number:
MFCD00068726
SMILES:
CSc1n[nH]nn1
NSC Number:
141852
Properties
Computed Properties
 
Complexity:
57.7  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
7  
Hydrogen Bond Acceptor Count:
4  
Hydrogen Bond Donor Count:
1  
Rotatable Bond Count:
1  
XLogP3:
0.3  

Literature

Title: Diethyldithiocarbamate induces apoptosis in HHV-8-infected primary effusion lymphoma cells via inhibition of the NF-κB pathway.

Journal: International journal of oncology 20120401

Title: Antitumor effect of berberine against primary effusion lymphoma via inhibition of NF-κB pathway.

Journal: Cancer science 20120401

Title: Deficient spindle assembly checkpoint in multiple myeloma.

Journal: PloS one 20110101

Title: C/EBPalpha is up-regulated in a subset of hepatocellular carcinomas and plays a role in cell growth and proliferation.

Journal: Gastroenterology 20100801

Title: Arsenic inhibits myogenic differentiation and muscle regeneration.

Journal: Environmental health perspectives 20100701

Title: Biscoclaurine alkaloid cepharanthine inhibits the growth of primary effusion lymphoma in vitro and in vivo and induces apoptosis via suppression of the NF-kappaB pathway.

Journal: International journal of cancer 20090915

Title: Chemical synthesis, characterization, and biocompatibility study of hydroxyapatite/chitosan phosphate nanocomposite for bone tissue engineering applications.

Journal: International journal of biomaterials 20090101

Title: In vitro simulation study of individualized chemotherapy in lung cancer.

Journal: Journal of Nippon Medical School = Nippon Ika Daigaku zasshi 20070601

Title: A new hormonal therapy for estrogen receptor-negative breast cancer.

Journal: World journal of surgery 20070501

Title: Nelfinavir potentiation of imatinib cytotoxicity in meningioma cells via survivin inhibition.

Journal: Neurosurgical focus 20070101

Title: Biocompatability of hydroxyapatite composite as a local drug delivery system.

Journal: Journal of orthopaedic surgery (Hong Kong) 20061201

Title: Ubiquitous expression of cyclooxygenase-2 in meningiomas and decrease in cell growth following in vitro treatment with the inhibitor celecoxib: potential therapeutic application.

Journal: Journal of neurosurgery 20050901

Title: Two dimorphs of 5-methylsulfanyl-1H-tetrazole.

Journal: Acta crystallographica. Section C, Crystal structure communications 20040101

Title: Estrogen and androgen receptors as comediators of breast cancer cell proliferation: providing a new therapeutic tool.

Journal: Archives of surgery (Chicago, Ill. : 1960) 20040101

Title: Combination therapy with irinotecan and protein kinase C inhibitors in malignant glioma.

Journal: Cancer 20030501

Title: Recovery of chondrocyte metabolic activity after thermal exposure.

Journal: The American journal of sports medicine 20030101

Title: Effects of berberine on glucose metabolism in vitro.

Journal: Metabolism: clinical and experimental 20021101

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 29515-99-9
Tags:29515-99-9 Molecular Formula|29515-99-9 MDL|29515-99-9 SMILES|29515-99-9 2H-Tetrazole, 5-(methylthio)-